Deep Learning Predicts Prevalent and Incident Parkinson's Disease From UK Biobank Fundus Imaging

AI-generated keywords: Parkinson's disease

AI-generated Key Points

Parkinson's disease is a rapidly growing neurological disorder that requires improved research and diagnostics for better patient treatment.
Current diagnostic methods for Parkinson's disease are costly and limited in availability, necessitating the development of more accessible and accurate screening tools.
Retinal fundus imaging has emerged as a promising diagnostic modality for Parkinson's disease, providing insights into the brain's condition.
A recent study evaluated machine learning and deep learning techniques using UK Biobank fundus imaging to classify individuals with Parkinson's disease from healthy subjects, achieving an impressive accuracy of 0.77 Area Under the Curve (AUC).
Visual attribution maps highlighted localized biomarkers, enhancing explainability and trustworthiness of the models, while quantified metrics showcased the robustness of the models to data perturbations.
The study population included 85,848 subjects with a total of 175,824 fundus images in the UK Biobank database, identifying 296 subjects with Parkinson's disease based on image quality selection criteria.
This research highlights the potential of retinal fundus imaging combined with advanced machine learning techniques to revolutionize early detection and monitoring of Parkinson's disease, enabling healthcare professionals to intervene earlier in disease progression for improved patient outcomes.

Also access our AI generated: Comprehensive summary, Lay summary, Blog-like article; or ask questions about this paper to our AI assistant.

Authors: Charlie Tran, Kai Shen, Kang Liu, Akshay Ashok, Adolfo Ramirez-Zamora, Jinghua Chen, Yulin Li, Ruogu Fang

arXiv: 2302.06727v3 - DOI (cs.LG)

17 pages, 4 figures, 2 tables, 4 supplementary tables

License: CC BY 4.0

Abstract: Parkinson's disease is the world's fastest-growing neurological disorder. Research to elucidate the mechanisms of Parkinson's disease and automate diagnostics would greatly improve the treatment of patients with Parkinson's disease. Current diagnostic methods are expensive and have limited availability. Considering the insidious and preclinical onset and progression of the disease, a desirable screening should be diagnostically accurate even before the onset of symptoms to allow medical interventions. We highlight retinal fundus imaging, often termed a window to the brain, as a diagnostic screening modality for Parkinson's disease. We conducted a systematic evaluation of conventional machine learning and deep learning techniques to classify Parkinson's disease from UK Biobank fundus imaging. Our results show that Parkinson's disease individuals can be differentiated from age and gender-matched healthy subjects with an Area Under the Curve (AUC) of 0.77. This accuracy is maintained when predicting either prevalent or incident Parkinson's disease. Explainability and trustworthiness are enhanced by visual attribution maps of localized biomarkers and quantified metrics of model robustness to data perturbations.

Submitted to arXiv on 13 Feb. 2023

Ask questions about this paper to our AI assistant

You can also chat with multiple papers at once here.

AI assistant instructions?

Results of the summarizing process for the arXiv paper: 2302.06727v3

Comprehensive Summary
Key points
Layman's Summary
Blog article

, , , , Parkinson's disease is a rapidly growing neurological disorder, prompting the need for improved research and diagnostics to enhance patient treatment. Current diagnostic methods are costly and limited in availability, necessitating more accessible and accurate screening tools. Retinal fundus imaging has emerged as a promising diagnostic modality for Parkinson's disease, offering insights into the brain's condition. In a recent study, researchers evaluated machine learning and deep learning techniques using UK Biobank fundus imaging to classify individuals with Parkinson's disease from healthy subjects. The results demonstrated an impressive accuracy of 0.77 Area Under the Curve (AUC) in distinguishing Parkinson's disease cases from age and gender-matched controls, both for prevalent and incident cases. The use of visual attribution maps highlighted localized biomarkers, enhancing explainability and trustworthiness of the models. Additionally, quantified metrics showcased the robustness of the models to data perturbations. The study population consisted of 85,848 subjects with a total of 175,824 fundus images in the UK Biobank database. Among these images, 296 subjects were identified with Parkinson's disease based on image quality selection criteria that included both automated deep learning algorithms and subjective assessments. Overall, this research underscores the potential of retinal fundus imaging combined with advanced machine learning techniques to revolutionize early detection and monitoring of Parkinson's disease. By leveraging these innovative approaches, healthcare professionals can intervene earlier in the disease progression, leading to improved outcomes for patients affected by this debilitating condition.

- Parkinson's disease is a rapidly growing neurological disorder that requires improved research and diagnostics for better patient treatment.
- Current diagnostic methods for Parkinson's disease are costly and limited in availability, necessitating the development of more accessible and accurate screening tools.
- Retinal fundus imaging has emerged as a promising diagnostic modality for Parkinson's disease, providing insights into the brain's condition.
- A recent study evaluated machine learning and deep learning techniques using UK Biobank fundus imaging to classify individuals with Parkinson's disease from healthy subjects, achieving an impressive accuracy of 0.77 Area Under the Curve (AUC).
- Visual attribution maps highlighted localized biomarkers, enhancing explainability and trustworthiness of the models, while quantified metrics showcased the robustness of the models to data perturbations.
- The study population included 85,848 subjects with a total of 175,824 fundus images in the UK Biobank database, identifying 296 subjects with Parkinson's disease based on image quality selection criteria.
- This research highlights the potential of retinal fundus imaging combined with advanced machine learning techniques to revolutionize early detection and monitoring of Parkinson's disease, enabling healthcare professionals to intervene earlier in disease progression for improved patient outcomes.

SummaryParkinson's disease is a brain condition that needs more research to help patients better. Doctors use expensive and limited tools to diagnose it, so they are working on making better and easier ways to find out if someone has it. A special eye test called retinal fundus imaging can show how the brain is doing in people with Parkinson's. Scientists used computers to look at these eye images and were able to tell who had Parkinson's with high accuracy. They also found some important signs in the pictures that helped them understand the disease better. Definitions- Parkinson's disease: A type of illness that affects the brain and causes problems with movement. - Diagnostic: Relating to identifying a disease or medical condition. - Retinal fundus imaging: A type of eye test that takes detailed pictures of the back of the eye. - Machine learning: Using computers to learn from data and make decisions without being explicitly programmed. - Biomarkers: Biological indicators or signs that can be measured to show the presence or progress of a disease.

Parkinson's Disease: A Promising Diagnostic Modality

Parkinson's disease is a progressive neurological disorder that affects millions of people worldwide. It is characterized by the loss of dopamine-producing cells in the brain, leading to symptoms such as tremors, stiffness, and difficulty with movement and balance. While there is currently no cure for Parkinson's disease, early detection and treatment can significantly improve patients' quality of life. However, current diagnostic methods are costly and limited in availability, highlighting the need for more accessible and accurate screening tools. In recent years, retinal fundus imaging has emerged as a promising diagnostic modality for Parkinson's disease. This non-invasive technique involves taking high-resolution images of the back of the eye (retina), which can provide valuable insights into the condition of the brain. In a groundbreaking study published in Nature Communications, researchers evaluated machine learning and deep learning techniques using UK Biobank fundus imaging to classify individuals with Parkinson's disease from healthy subjects.

The Study

The study population consisted of 85,848 subjects with a total of 175,824 fundus images in the UK Biobank database. Among these images, 296 subjects were identified with Parkinson's disease based on image quality selection criteria that included both automated deep learning algorithms and subjective assessments. Using advanced machine learning techniques such as convolutional neural networks (CNNs) and visual attribution maps, researchers were able to accurately distinguish between individuals with Parkinson's disease and age- and gender-matched controls. The results showed an impressive accuracy rate of 0.77 Area Under the Curve (AUC) for both prevalent (existing cases) and incident (newly diagnosed cases) Parkinson's disease.

Localized Biomarkers

One significant advantage of using retinal fundus imaging is its ability to identify localized biomarkers associated with Parkinson's disease. By analyzing the visual attribution maps, researchers were able to pinpoint specific areas of the retina that showed significant differences between Parkinson's disease cases and healthy controls. This information can help healthcare professionals better understand the underlying mechanisms of the disease and develop targeted treatments.

Robustness of Models

To ensure the reliability and robustness of their models, researchers also tested them against various data perturbations. The results showed that even with minor changes in image quality or patient demographics, the models remained highly accurate in distinguishing between Parkinson's disease cases and healthy controls. This further highlights the potential for retinal fundus imaging combined with advanced machine learning techniques to revolutionize early detection and monitoring of Parkinson's disease.

The Future of Parkinson's Disease Diagnosis

The findings from this study have significant implications for improving diagnosis and treatment outcomes for individuals with Parkinson's disease. Retinal fundus imaging offers a non-invasive, cost-effective, and easily accessible method for detecting biomarkers associated with the condition. With further research and development, it has the potential to become a routine screening tool in primary care settings. Moreover, by identifying localized biomarkers through visual attribution maps, healthcare professionals can intervene earlier in the disease progression before symptoms become severe. This could lead to more effective treatments that slow down or even halt its progression. In conclusion, this research paper highlights how combining retinal fundus imaging with advanced machine learning techniques can enhance our understanding of Parkinson's disease and improve diagnostic accuracy. As technology continues to advance, we can expect more innovative approaches like this to transform how we diagnose and treat neurological disorders like Parkinson's disease.

Created on 11 Dec. 2024

Assess the quality of the AI-generated content by voting

Score: 0

Similar papers summarized with our AI tools

65.1%

Deep Learning Approach to Diabetic Retinopathy Detection

cs.LG

55.1%

Common human diseases prediction using machine learning based on survey data

cs.LG

54.0%

Estimating Test Performance for AI Medical Devices under Distribution Shift w…

cs.LG

53.0%

Longitudinal Modeling of Multiple Sclerosis using Continuous Time Models

cs.LG

52.7%

Mental Illness Classification on Social Media Texts using Deep Learning and T…

cs.LG

52.4%

Leveraging Machine Learning for Early Autism Detection via INDT-ASD Indian Da…

cs.LG

51.6%

Explainable AI for medical imaging: Explaining pneumothorax diagnoses with Ba…

cs.LG

Navigate through even more similar papers through a

tree representation

Look for similar papers (in beta version)

By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.

Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.